Detalhe da pesquisa
1.
Real-world outcomes of ponatinib treatment in 724 patients with CML and Ph+ ALL: a post-marketing surveillance study with a special interest in arterial occlusive events in Japan.
Jpn J Clin Oncol
; 2024 May 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-38747937
2.
Phase 2 study of axicabtagene ciloleucel in Japanese patients with relapsed or refractory large B-cell lymphoma.
Int J Clin Oncol
; 27(1): 213-223, 2022 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-34599413
3.
Phase I, multicenter, dose-escalation study of avadomide in adult Japanese patients with advanced malignancies.
Cancer Sci
; 112(1): 331-338, 2021 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-33075165
4.
Factors for the optimal selection of granulocyte colony-stimulating factor preparations and predictors for R-CHOP dose reductions/delays among patients with non-Hodgkin B-cell lymphoma (STOP FN in NHL 2 subanalysis).
BMC Cancer
; 21(1): 358, 2021 Apr 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-33823836
5.
Safety and pharmacokinetics of polatuzumab vedotin in Japanese patients with relapsed/refractory B-cell non-Hodgkin lymphoma: a phase 1 dose-escalation study.
Jpn J Clin Oncol
; 51(1): 70-77, 2021 Jan 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-33029633
6.
Incidence and risk factors for febrile neutropenia in Japanese patients with non-Hodgkin B cell lymphoma receiving R-CHOP: 2-year experience in a single center (STOP FN in NHL 2).
Support Care Cancer
; 28(2): 571-579, 2020 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-31093770
7.
Phase I study of tirabrutinib (ONO-4059/GS-4059) in patients with relapsed or refractory B-cell malignancies in Japan.
Cancer Sci
; 110(5): 1686-1694, 2019 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-30815927
8.
Carfilzomib monotherapy in Japanese patients with relapsed or refractory multiple myeloma: A phase 1/2 study.
Cancer Sci
; 110(9): 2924-2932, 2019 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-31336012
9.
BCL2 expression in DLBCL: reappraisal of immunohistochemistry with new criteria for therapeutic biomarker evaluation.
Blood
; 130(4): 489-500, 2017 07 27.
Artigo
em Inglês
| MEDLINE | ID: mdl-28522442
10.
Multicenter phase 1/2 study of forodesine in patients with relapsed peripheral T cell lymphoma.
Ann Hematol
; 98(1): 131-142, 2019 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-29974231
11.
Pattern of Tumor Shrinkage during Neoadjuvant Chemotherapy Is Associated with Prognosis in Low-Grade Luminal Early Breast Cancer.
Radiology
; 286(1): 49-57, 2018 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-28737968
12.
Epstein-Barr virus-negative extranodal "true" natural killer-cell lymphoma harbouring a KDM6A mutation.
Hematol Oncol
; 36(1): 328-335, 2018 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-28695659
13.
Delayed recovery of serum immunoglobulin G is a poor prognostic marker in patients with follicular lymphoma treated with rituximab maintenance.
Ann Hematol
; 97(2): 289-297, 2018 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-29138885
14.
Correction to: Multicenter phase 1/2 study of forodesine in patients with relapsed peripheral T cell lymphoma.
Ann Hematol
; 97(12): 2529-2530, 2018 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-30054705
15.
Safety, tolerability and pharmacokinetics of shorter duration of infusion of obinutuzumab in Japanese patients with B-cell non-Hodgkin lymphoma: final results of the phase II GATS study.
Jpn J Clin Oncol
; 48(8): 736-742, 2018 Aug 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-30060000
16.
Multicenter phase II study of nivolumab in Japanese patients with relapsed or refractory classical Hodgkin lymphoma.
Cancer Sci
; 108(5): 1007-1012, 2017 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-28267244
17.
Incidence and risk factors of febrile neutropenia in patients with non-Hodgkin B-cell lymphoma receiving R-CHOP in a single center in Japan.
Support Care Cancer
; 25(11): 3313-3320, 2017 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-28551843
18.
Frequent BCOR aberrations in extranodal NK/T-Cell lymphoma, nasal type.
Genes Chromosomes Cancer
; 55(5): 460-71, 2016 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-26773734
19.
Combination therapy with monoclonal antibodies for treatment of newly diagnosed multiple myeloma.
Rinsho Ketsueki
; 58(8): 1006-1013, 2017.
Artigo
em Japonês
| MEDLINE | ID: mdl-28883263
20.
Efficacy of chemotherapy in extremely elderly patients with diffuse large B-cell lymphoma.
Rinsho Ketsueki
; 58(5): 427-432, 2017.
Artigo
em Japonês
| MEDLINE | ID: mdl-28592754